Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1190, Vienna, Austria.
Malar J. 2012 May 7;11:158. doi: 10.1186/1475-2875-11-158.
Severe falciparum malaria is associated with considerable rates of mortality, despite the administration of appropriate anti-malarial treatment. Since overall survival is associated with total parasite biomass, blood exchange transfusion has been proposed as a potential method to rapidly reduce peripheral parasitaemia. However, current evidence suggests that this treatment modality may not improve outcome. Automated red blood cell exchange (also referred to as "erythrocytapheresis") has been advocated as an alternative method to rapidly remove parasites from circulating blood without affecting patients' volume and electrolyte status. However, only limited evidence from case reports and case series is available for this adjunctive treatment. This retrospective cohort study describes the use of automated red blood cell exchange for the treatment of severe malaria at the Medical University of Vienna.
Epidemiologic data for imported malaria cases in Austria are reported and data of patients treated for malaria at the General Hospital/Medical University of Vienna were extracted from electronic hospital records.
Between 2000 and 2010, 146 patients were hospitalized at the Medical University of Vienna due to malaria and 16 of those were classified as severe malaria cases. Eleven patients of this cohort were potentially eligible for an adjunctive treatment with automated red blood cell exchange. Five patients eventually underwent this procedure within a period of seven hours (range: 3-19 hours) after hospital admission. Six patients did not undergo this adjunctive treatment following the decision of the treating physician. The procedure was well tolerated in all cases and rapid reduction in parasite counts was achieved without occurrence of haemodynamic complications. One patient died within seven days, whereas four patients survived without any sequelae.
Automated red blood cell exchange was a safe and efficient procedure to rapidly clear peripheral parasitaemia. Whether the fast reduction in parasite biomass may ultimately improve patient survival remains however unclear. Randomized controlled trials are needed to conclusively appreciate the value of this adjunctive treatment.
尽管给予了适当的抗疟治疗,恶性疟仍与相当高的死亡率相关。由于总生存与寄生虫总生物量相关,故有人提出血液交换输血作为一种快速降低外周寄生虫血症的潜在方法。然而,目前的证据表明这种治疗方式可能无法改善预后。自动化红细胞交换(也称为“红细胞分离术”)已被提倡作为一种替代方法,可在不影响患者容量和电解质状态的情况下,快速从循环血液中去除寄生虫。然而,对于这种辅助治疗,仅有有限的来自病例报告和病例系列的证据。本回顾性队列研究描述了在维也纳医科大学使用自动化红细胞交换治疗严重疟疾的情况。
报道了奥地利输入性疟疾病例的流行病学数据,并从维也纳总医院/医科大学的电子病历中提取了疟疾治疗患者的数据。
2000 年至 2010 年期间,维也纳医科大学有 146 名疟疾住院患者,其中 16 名被归类为严重疟疾病例。该队列中有 11 名患者可能有资格接受自动化红细胞交换的辅助治疗。5 名患者在入院后 7 小时内(范围:3-19 小时)进行了该程序。6 名患者未接受该辅助治疗,原因是主治医生的决定。所有病例均耐受良好,寄生虫计数迅速减少,无血流动力学并发症发生。1 名患者在 7 天内死亡,4 名患者存活且无任何后遗症。
自动化红细胞交换是一种安全有效的清除外周寄生虫血症的方法。快速降低寄生虫生物量是否最终能提高患者生存率尚不清楚。需要进行随机对照试验才能最终确定这种辅助治疗的价值。